Eiger BioPharmaceuticals, Inc. EIGR
1.73 0.00 0.00%
At close · Jun 17
52-week range unavailable
- Open
- 1.90
- Prev close
- 1.73
- Mkt cap
- 2.55M
- Vol
- 136.27K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.73
- High
- 1.90
- Forward P/E
- -0.48
- Beta
- 1.84
- Short ratio
- 3.72
- Inst. own
- 43.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 4.59
- 200-d avg
- 10.27
- 1y target
- 30.00
3M chart
Chart tools
Chart is warming up
The three-month price history for EIGR has not been loaded yet. Try again in a moment.
Altman Z-Score
-24.42 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.1×
P/S 0.6×
P/B -0.7×
P/FCF -0.1×
EV/EBITDA -0.4×
EV/Sales 1.6×
FCF Yield -751.6%
Gross Margin 99.8%
Operating Margin -455.1%
Net Margin -475.3%
ROE 518.5%
ROIC -268.4%
ROA -193.1%
Revenue 17.0%
Operating Income 22.6%
EPS (diluted) 27.2%
Free Cash Flow 10.3%
Current Ratio 0.7×
Quick Ratio 0.7×
Debt / Equity -2.8×
Net Debt / EBITDA -0.2×
Interest Coverage -13.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31